Top 10 Stocks Warren Buffett Would Buy in 2026

Page 8 of 10

3. United Therapeutics Corporation (NASDAQ:UTHR)

Number of Hedge Fund Holders: 68

United Therapeutics Corporation (NASDAQ:UTHR) is one of the top 10 stocks Warren Buffett would buy in 2026.

On February 26, 2026, H.C. Wainwright raised the price target on United Therapeutics Corporation (NASDAQ:UTHR) from $525 to $600 while maintaining a Buy rating. The company has announced that it is developing a soft mist inhaler for treprostinil, slated for a 2027 launch to treat PAH and PH-ILD. In the analyst note, H.C. Wainwright sees this as a strategic move to counter competitors like Yutrepia while evolving the Tyvaso franchise. The management reaffirmed its target of a $4 billion revenue run rate by late 2027, while it awaits the upcoming Phase 3 data for ralinepag and IPF treatments. The firm anticipates upside to this target.

On the same day, RBC Capital analyst Lisa Walter also raised United Therapeutics Corporation’s (NASDAQ:UTHR) target price from $587 to $643 while keeping an Outperform rating on the stock. Similar to H.C. Wainwright, RBC Capital analyst also cited the new announcement for a soft mist inhaler for Treprostinil that could be preferred over DPIs.

Founded in 1996, United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company focused on rare diseases such as pulmonary arterial hypertension. Its co-headquarters are in Maryland and North Carolina.

Page 8 of 10